搜索临床试验以:intravitreal ranibizumab,
总计1405个结果
-
Brandon G. Busbee, MDGenentech, Inc.完全的
-
Seoul Retina Investigator GroupSamsung Medical Center; Kyungpook National University Hospital未知
-
David M. Brown, M.D.Genentech, Inc.完全的
-
Southeast Clinical Research Associates, LLCGenentech, Inc.完全的
-
Charles C Wykoff, PhD, MDGenentech, Inc.完全的
-
University of California, San DiegoGenentech, Inc.终止
-
Mie University未知
-
University Health Network, Toronto完全的
-
JHSPH Center for Clinical TrialsNational Eye Institute (NEI)完全的
-
Novartis Pharmaceuticals完全的
-
Johns Hopkins UniversityJuvenile Diabetes Research Foundation完全的
-
Leonard Feiner, MD, PhDNJ Retina (Retina Associates of New Jersey)完全的
-
Eye Center of Northern Colorado, P.C.Genentech, Inc.完全的
-
Steven R. SanisloGenentech, Inc.; California Pacific Medical Center; Pacific Eye Associates完全的
-
Aerpio Therapeutics完全的
-
Novartis Pharmaceuticals完全的
-
Manhattan Eye, Ear & Throat HospitalGenentech, Inc.完全的息肉状脉络膜血管病变 | 弹性假黄瘤 | 病理性近视 | 视网膜血管瘤增生 | 大衣病 | 特发性视网膜毛细血管扩张症 | 多灶性脉络膜炎 | 虹膜红斑病 | 希佩尔林道病 | 最佳黄斑黄斑营养不良,多灶性(疾病)美国
-
Novartis Pharmaceuticals完全的黄斑水肿 | 视力障碍 | 视网膜分支静脉阻塞德国, 英国, 匈牙利, 波兰, 捷克共和国
-
Shanghai Biomabs Pharmaceutical Co., Ltd.完全的
-
David M. Brown, M.D.Genentech, Inc.终止
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)完全的
-
Maisonneuve-Rosemont HospitalNovartis完全的
-
Southeast Clinical Research Associates, LLCRegeneron Pharmaceuticals撤销
-
Alcon ResearchNovartis Institutes for BioMedical Research撤销糖尿病性黄斑水肿